Children with juvenile idiopathic arthritis (JIA) undergoing early and aggressive combination drug therapy achieve clinical inactive disease more quickly than with less aggressive therapy, researchers reported at the… read more.
Functional abdominal pain in childhood was associated with anxiety disorder and depression in teens and young adults, even if the stomach pain went away, a longitudinal study showed.
by Bruce Sylvester – Alogliptin treatment of patients with type 2 diabetes and with high cardiovascular risk due to recent acute coronary syndromes has led to similar rates… read more.
‘Big 4’ Journal Highlights – New England Journal of Medicine (NEJM) – by Bruce Sylvester – Research published on Aug. 7, 2013 in the New England Journal of Medicine/NEJM indicates… read more.
by Pam Harrison – MSI status has clear prognostic value in stage II CRC Julien Taieb, MD, PhD, University of Paris Descartes, Paris, France Microsatellite instability (MSI), a… read more.
If you have trouble going to sleep at night and waking up for work or school in the morning, a week of camping in the great outdoors might… read more.
Taken from the Lancet – by Bruce Sylvester – High doses of some non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of major vascular events (non-fatal heart attacks, strokes,… read more.
FDA Highlights by Bruce Sylvester – Researchers report that finasteride appears to reduce alcohol consumption in some men. The results were published online on June 13, 2013 by Alcoholism:… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
A newly-described immunodeficiency syndrome of neutrophil defects, bone marrow fibrosis, nephromegaly, and life-threatening infections arises from a genetic mutation that impairs movement of proteins within cells, researchers found.
The American Society of Clinical Oncology (ASCO) kicked off its 49th Annual Meeting with leaders urging all stakeholders in cancer care to vigorously oppose cuts to vital US… read more.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
